Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-06-18

Clinical Trial Results: Cannabidiol in the Treatment of Opioid Use Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results on cannabidiol for opioid use disorder have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabidiol (cannabidiol)

Snippet

Sponsor: Yasmin Hurd | Conditions: Opioid Use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2026-06-18